返回 Agenda
S9 - Practical Implementation of Next-Generation Post-Marketing Safety Studies
Session Chair(s)
Min-Jung Lim, MPHARM, RPH
CEO & Senior Pharmacovigilance Consultant
MediSafe, Pharmacovigilance Services, Korea, Republic of
Seongsik Kang, MD
Senior Vice President
HANDOK, Inc, Korea, Republic of
Speaker(s)
Current Status of RWD-Based Safety Studies (Database Studies) in Japanese PMS
Fuminori Okubo
CMIC Co., Ltd., Japan
Director, Strategic Excellence Dept, RWD Solutions Div.
Case Study : RWD-Based Safety Study in RMP – Korea
Hye Young Kim, MD, PHD
SK bioscience, Korea, Republic of
VP, Head of Medical Affairs
Practical Implementation of Next-Generation Post-Marketing Safety Studies From RMP Safety Questions to Practical RWD Study Design in Korea
Seong-jun Byun, PHD
DreamCIS Inc., Korea, Republic of
Director
Seung Hee Jeong, PHD
Pfizer Korea, Korea, Republic of
RWE Generation Team Lead,
Jung Ae Kim, PHD
Inje University, Korea, Republic of
Professor, Pharmacogenomics Research Center
So Hee Kim, PHD
National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of
Director / Ministry of Food and Drug Safety